Post-engraftment Bloodstream Infections After Allogeneic Hematopoietic Cell Transplantation: Risk Factors and Association with Mortality
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Bloodstream infections (BSIs) are major cause of morbidity and mortality after allogeneic hematopoietic cell transplantation (allo-HCT). This study aimed to analyze the incidence, etiology, risk factors and outcomes of post-engraftment BSI in allo-HCT recipients. Materials and Methods: The retrospective study included 261 patients with documented engraftment after first allo-HCT performed from January 2018 till September 2021. Results: Of 261 patients 29 (11.1%) developed at least one post-engraftment BSIs episode with a median time to post-engraftment BSI of 49 days (range, 1 - 158 days from the engraftment). A total of 45 pathogens were isolated from blood – 64.4% (n = 29) were represented by Gram-negative bacteria, and 35.6% (n = 16) – by Gram-positive bacteria. Secondary graft failure (hazard ratio [HR]: 39.93; 95% confidence interval [CI]: 7.64-208.74; P <0.001), secondary poor graft function (HR: 18.07; 95% CI: 3.53 - 92.44; P <0.001), and acute gut graft-versus-host-disease (GvHD) grade II-IV (HR: 29.86; 95% CI: 10.53 - 84.68; P <0.001) were associated with the higher risk of Gram-negative post-engraftment BSIs. Overall 30-day survival after post-engraftment BSIs was 71.4%. By multivariate analysis post-engraftment BSIs (HR: 3.09; 95% CI: 1.29 – 7.38; P = 0.011), and acute gut GvHD grade II-IV (HR: 6.60; 95% CI: 2.78 - 15.68; P <0.001) were associated with the higher 180-day non-relapse mortality risk. Conclusion: Gram-negative bacteria prevailed in the etiology of post-engraftment BSIs with secondary graft failure. secondary poor graft function. and acute gut GvHD being the main predisposing factors for their development. Post-engraftment BSIs were associated with the higher risk of non-relapse mortality after allo-HCT.
Abstract
Background: Bloodstream infections (BSIs) are major cause of morbidity and mortality after allogeneic hematopoietic cell transplantation (allo-HCT). This study aimed to analyze the incidence, etiology, risk factors and outcomes of post-engraftment BSI in allo-HCT recipients. Materials and Methods: The retrospective study included 261 patients with documented engraftment after first allo-HCT performed from January 2018 till September 2021. Results: Of 261 patients 29 (11.1%) developed at least one post-engraftment BSIs episode with a median time to post-engraftment BSI of 49 days (range, 1 - 158 days from the engraftment). A total of 45 pathogens were isolated from blood – 64.4% (n = 29) were represented by Gram-negative bacteria, and 35.6% (n = 16) – by Gram-positive bacteria. Secondary graft failure (hazard ratio [HR]: 39.93; 95% confidence interval [CI]: 7.64-208.74; P <0.001), secondary poor graft function (HR: 18.07; 95% CI: 3.53 - 92.44; P <0.001), and acute gut graft-versus-host-disease (GvHD) grade II-IV (HR: 29.86; 95% CI: 10.53 - 84.68; P <0.001) were associated with the higher risk of Gram-negative post-engraftment BSIs. Overall 30-day survival after post-engraftment BSIs was 71.4%. By multivariate analysis post-engraftment BSIs (HR: 3.09; 95% CI: 1.29 – 7.38; P = 0.011), and acute gut GvHD grade II-IV (HR: 6.60; 95% CI: 2.78 - 15.68; P <0.001) were associated with the higher 180-day non-relapse mortality risk. Conclusion: Gram-negative bacteria prevailed in the etiology of post-engraftment BSIs with secondary graft failure. secondary poor graft function. and acute gut GvHD being the main predisposing factors for their development. Post-engraftment BSIs were associated with the higher risk of non-relapse mortality after allo-HCT.
참고문헌 (15)
- Dandoy CE, "Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient : new considerations for a persistent nemesis", Bone Marrow Transplant, 52, pp.1091~1106 (2017)
- Akhmedov M, "Incidence, etiology, risk factors, and outcomes of pre-engraftment bloodstream infections after first and second allogeneic hematopoietic cell transplantation", Transpl Infect Dis, 24, pp.e13842~ (2022)
- Choi Hyeah, "Bloodstream Infections in Patients with Hematologic Diseases: Causative Organisms and Factors Associated with Resistance", Infection and Chemotherapy, 54(2), pp.340~352 (2022), 대한감염학회[DOI]
- Kikuchi M, "Risk factors for pre-and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation", Transpl Infect Dis, 17, pp.56~65 (2015)
- Ustun C, "Bacterial blood stream infections(BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation", Bone Marrow Transplant, 54, pp.1254~1265 (2019)
- Almyroudis NG, "Pre-and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients", Transpl Infect Dis, 7, pp.11~17 (2005)
- Mori Y, "Gastrointestinal graft-versus-host disease is a risk factor for postengraftment bloodstream infection in allogeneic hematopoietic stem cell transplant recipients", Biol Blood Marrow Transplant, 24, pp.2302~2309 (2018)
- Eryilmaz-Eren Esma, "Bacteremia in Hematopoietic Stem Cell Recipients Receiving Fluoroquinolone Prophylaxis: Incidence, Resistance, and Risk Factors", Infection and Chemotherapy, 54(3), pp.446~455 (2022), 대한감염학회[DOI]
- Akhmedov M, "Infectious complications in allogeneic hematopoietic cell transplant recipients : Review of transplant-related risk factors and current state of prophylaxis", Clin Transplant, 35, pp.e14172~ (2021)
- Averbuch D, "Intercontinental study on pre-engraftment and post-engraftment Gram-negative rods bacteremia in hematopoietic stem cell transplantation patients : risk factors and association with mortality", J Infect, 81, pp.882~894 (2020)
- Mikulska M, "Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients", J Infect, 68, pp.321~331 (2014)
- Averbuch D, "Antimicrobial resistance in Gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients : intercontinental prospective study of the infectious diseases working party of the European bone marrow transplantation group", Clin Infect Dis, 65, pp.1819~1828 (2017)
- Giske CG, "Update from the European committee on antimicrobial susceptibility testing(EUCAST)", J Clin Microbiol, 60, pp.e0027621~ (2022)
- Bacigalupo A, "Defining the intensity of conditioning regimens : working definitions", Biol Blood Marrow Transplant, 15, pp.1628~1633 (2009)
- Schoemans HM, "EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment", Bone Marrow Transplant, 53, pp.1401~1415 (2018)